K233533

Substantially Equivalent

NerveTape

Applicant: Biocircuit Technologies, Inc.
Product code: JXI
Advisory panel: Neurology
Date received: 2023-11-02
Decision date: 2024-02-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Atlanta, GA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.